Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Volitionrx (VNRX) Return on Sales (2019 - 2025)

Volitionrx (VNRX) has disclosed Return on Sales for 9 consecutive years, with 12.06% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Sales fell 1196.0% year-over-year to 12.06%, compared with a TTM value of 14.81% through Sep 2025, up 397.0%, and an annual FY2024 reading of 21.9%, up 2440.0% over the prior year.
  • Return on Sales was 12.06% for Q3 2025 at Volitionrx, down from 0.12% in the prior quarter.
  • Across five years, Return on Sales topped out at 5.13% in Q4 2021 and bottomed at 59.99% in Q1 2023.
  • Average Return on Sales over 5 years is 16.23%, with a median of 0.1% recorded in 2024.
  • The sharpest move saw Return on Sales soared 1066159bps in 2021, then plummeted -6073bps in 2023.
  • Year by year, Return on Sales stood at 5.13% in 2021, then plummeted by -85bps to 0.79% in 2022, then crashed by -4654bps to 35.79% in 2023, then grew by 16bps to 30.16% in 2024, then soared by 60bps to 12.06% in 2025.
  • Business Quant data shows Return on Sales for VNRX at 12.06% in Q3 2025, 0.12% in Q2 2025, and 22.41% in Q1 2025.